Boston Short Long Term Debt Total from 2010 to 2025

BSX Stock  USD 102.67  1.98  1.97%   
Boston Scientific Short and Long Term Debt Total yearly trend continues to be fairly stable with very little volatility. Short and Long Term Debt Total is likely to outpace its year average in 2025. During the period from 2010 to 2025, Boston Scientific Short and Long Term Debt Total regression line of annual values had r-squared of  0.89 and arithmetic mean of  6,934,218,750. View All Fundamentals
 
Short and Long Term Debt Total  
First Reported
1991-12-31
Previous Quarter
11.3 B
Current Value
11.1 B
Quarterly Volatility
3.6 B
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Boston Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boston Scientific's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 B, Interest Expense of 198.1 M or Selling General Administrative of 6.3 B, as well as many indicators such as Price To Sales Ratio of 4.7, Dividend Yield of 4.0E-4 or PTB Ratio of 5.9. Boston financial statements analysis is a perfect complement when working with Boston Scientific Valuation or Volatility modules.
  
Check out the analysis of Boston Scientific Correlation against competitors.

Latest Boston Scientific's Short Long Term Debt Total Growth Pattern

Below is the plot of the Short Long Term Debt Total of Boston Scientific Corp over the last few years. It is Boston Scientific's Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Boston Scientific's overall financial position and show how it may be relating to other accounts over time.
Short Long Term Debt Total10 Years Trend
Slightly volatile
   Short Long Term Debt Total   
       Timeline  

Boston Short Long Term Debt Total Regression Statistics

Arithmetic Mean6,934,218,750
Geometric Mean4,872,215,792
Coefficient Of Variation45.86
Mean Deviation2,706,568,750
Median7,056,000,000
Standard Deviation3,179,948,555
Sample Variance10112072.8T
Range11.3B
R-Value0.94
Mean Square Error1231217.8T
R-Squared0.89
Slope628,827,206
Total Sum of Squares151681092.2T

Boston Short Long Term Debt Total History

202511.3 B
202410.7 B
20239.5 B
20229.3 B
20219.5 B
20209.5 B
201910.3 B

About Boston Scientific Financial Statements

Boston Scientific investors use historical fundamental indicators, such as Boston Scientific's Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Boston Scientific. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short and Long Term Debt Total10.7 B11.3 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.